Literature DB >> 23996887

Long-term oxygen therapy in Japan: history, present status, and current problems.

Kozui Kida1, Takashi Motegi, Takeo Ishii, Kumiko Hattori.   

Abstract

Historically, the progress of long term-oxygen therapy (LTOT) in Japan has been characterized by collaboration among academic groups, policy makers, and industrial companies. The public health insurance program has covered the cost of LTOT since 1985. Thomas Petty's group in Denver enthusiastically carried out the public implementation of LTOT and conveyed the concept of pulmonary rehabilitation for the processing with LTOT. Although the target diseases of LTOT in Japan tended to be chronic obstructive pulmonary disease or sequelae of primary lung tuberculosis, it was soon applied for cardiac diseases as well as other pulmonary diseases. Together with increasing medical costs for geriatric patients, the political conversion from hospital based care of a traditional style to home care system has been performed, with two background reasons: the improvement of quality of life of patients and the reduction of the medical expense. Presently, LTOT plays a pivotal role in the successful implementation of home respiratory care for elderly patients. In addition, this promotes comprehensive pulmonary rehabilitation, a team approach, and close liaisons between primary care and hospitals. Currently, the total number of patients using LTOT exceeds 150,000. In Japan, LTOT resulted in an advancement in the medical care as well as in administrative decision to introduce it as a nationwide system after analyzing the results of opinion polls of patients with respiratory failure. However, the recent great earthquake in East Japan revealed that many unresolved problems remain for these patients, and these issues are of great concern.

Entities:  

Mesh:

Year:  2013        PMID: 23996887

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  7 in total

1.  Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapy.

Authors:  Manabu Hayama; Hidekazu Suzuki; Takayuki Shiroyama; Motohiro Tamiya; Norio Okamoto; Ayako Tanaka; Naoko Morishita; Takuji Nishida; Takashi Nishihara; Tomonori Hirashima
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  Can Homecare Chronic Respiratory Disease Patients with Home Oxygen Treatment (HOT) in Southern Okinawa, Japan Be Evacuated Ahead of the Next Anticipated Tsunami?

Authors:  Hiroshi Sekiguchi; Rie Takeuchi; Yoko Sato; Tsuyoshi Matsumoto; Jun Kobayashi; Takehiro Umemura
Journal:  Int J Environ Res Public Health       Date:  2022-05-06       Impact factor: 4.614

3.  Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy.

Authors:  Yu Hara; Atsuya Takeda; Takahisa Eriguchi; Naoko Sanuki; Yousuke Aoki; Shuichi Nishimura; Tatsuji Enomoto; Masaharu Shinkai; Akihiko Kawana; Takeshi Kaneko
Journal:  J Radiat Res       Date:  2015-10-20       Impact factor: 2.724

Review 4.  Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

Authors:  Marcela Muñoz-Torrico; Adrian Rendon; Rosella Centis; Lia D'Ambrosio; Zhenia Fuentes; Carlos Torres-Duque; Fernanda Mello; Margareth Dalcolmo; Rogelio Pérez-Padilla; Antonio Spanevello; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

Review 5.  Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries.

Authors:  Takeo Ishii; Masaharu Nishimura; Asako Akimoto; Mark H James; Paul Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-26

6.  Current Status of the Treatment of COPD in China: A Multicenter Prospective Observational Study.

Authors:  Yuqin Zeng; Shan Cai; Yan Chen; Jiaxi Duan; Yiyang Zhao; Xin Li; Libing Ma; Qimi Liu; Yingqun Zhu; Ming Chen; Meiling Zhou; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-07

Review 7.  Narrative review of current COPD status in Japan.

Authors:  Naoya Tanabe; Susumu Sato
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.